CRMD

EPS: 0.43 Rev: 127M Net Inc: 39M

Income Statement

Expenses

Tax

Assets

Assets (Current)

Assets (Non-Current)

Liabilities

Liabilities (Current)

Liabilities (Non-Current)

Cash Flow

Cash Flow Investing

Cash Flow Financing

CRMD vs Biotechnology (76 peers) - Healthcare

Gross Margin

88.5%

+11.8pp vs peers

Operating Margin

48.2%

+17.5pp vs peers

Net Margin

52.3%

+26.8pp vs peers

ROIC

43.2%

-54.2pp vs peers

Dimension Breakdowns

us-gaap:SharesOutstanding

us-gaap:StatementEquityComponentsAxis

Leaf Members

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis

Leaf Members

Related: REGN INCY VRTX NTLA SVRA ARDX ALLO IOVA CHRS CPRX